Citigroup
HSTO

Citigroup’s Histogen Inc. Common Stock HSTO Stock Holding History

Citigroup’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-48
Closed -$3K – 7876
2019
Q3 		$3K Sell
48
-39
-45% -$2.54K ﹤0.01% 7502
2019
Q2 		$4K Buy
87
+16
+23% +$2.78K ﹤0.01% 7549
2019
Q1 		$15K Buy
71
+23
+48% +$9.28K ﹤0.01% 7105
2018
Q4 		$17K Buy
48
+28
+140% +$21.8K ﹤0.01% 6965
2018
Q3 		$23K Sell
20
-13
-39% -$12K ﹤0.01% 7027
2018
Q2 		$28K Sell
33
-38
-54% -$31.6K ﹤0.01% 6757
2018
Q1 		$83K Buy
71
+50
+238% +$55.3K ﹤0.01% 5766
2017
Q4 		$19K Sell
21
-119
-85% -$110K ﹤0.01% 6764
2017
Q3 		$153K Sell
140
-23
-14% -$26.2K ﹤0.01% 5213
2017
Q2 		$188K Buy
163
+149
+1,064% +$181K ﹤0.01% 4854
2017
Q1 		$16K Sell
14
-300
-96% -$290K ﹤0.01% 6374
2016
Q4 		$330K Buy
314
+87
+38% +$39.5K ﹤0.01% 4814
2016
Q3 		$91K Buy
227
+206
+981% +$84K ﹤0.01% 5268
2016
Q2 		$8K Sell
21
-71
-77% -$34.8K ﹤0.01% 6658
2016
Q1 		$39K Buy
92
+1
+1% +$386 ﹤0.01% 6238
2015
Q4 		$52K Sell
91
-79
-46% -$55.3K ﹤0.01% 5920
2015
Q3 		$151K Buy
170
+162
+2,025% +$148K ﹤0.01% 4711
2015
Q2 		$8K Buy
+8
New +$9.38K ﹤0.01% 6589

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's HSTO Position: Q3 2021 in Review

Citigroup sold out of Histogen Inc. Common Stock (HSTO) in Q3 2021, closing a stake of 5 shares.

Citigroup first reported a position in HSTO in Q4 2013 and held it in 28 quarters. The position peaked at $703K in Q3 2015. 22 funds tracked by Wall St. Rank hold HSTO as of Q3 2021.

  • Citigroup reported no remaining Histogen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 5 Histogen Inc. Common Stock shares in Q3 2021.
  • Citigroup first reported a position in Histogen Inc. Common Stock in Q4 2013 and held it in 28 quarters.
  • Citigroup's Histogen Inc. Common Stock position peaked at $703K in Q3 2015.
  • 22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.